DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Zinzani PL, Viviani S, Anastasia A et al.
Brentuximab vedotin in relapsed/refractory Hodgkin’s lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials.
Haematologica 2013;
98: 1232-1236
We do not assume any responsibility for the contents of the web pages of other providers.